双乙酰丙酮氧钒对人肾上腺皮质癌细胞增殖和侵袭的影响

doi:10.3969/j.issn.1006-5725.2025.06.002

Abstract

Abstract:

Objective To investigate the effects of bis（acetylacetonato）oxovanadium（IV）［VO（acac）?］ on human adrenocortical carcinoma cell lines SW?13 and NCI?H295R in vitro， aiming to determine whether VO（acac）? promotes or inhibits the proliferation， migration， and invasion of these cells. Methods SW?13 and NCI?H295R cells in logarithmic growth phase were exposed to VO（acac）? at concentrations of 6.25， 12.5， 25， 50， 75， 100， and 200 μmol/L for 24 and 48 hours， respectively. Mitotane served as the positive control. Cell viability was assessed using the CCK?8 assay to evaluate the effects of VO（acac）? on SW?13 and NCI?H295R cells. Subsequently， cells were treated with VO（acac）? at concentrations of 0， 6.25， 12.5， and 25 μmol/L for 48 hours， and flow cytometry was employed to investigate the impact of VO（acac）? on apoptosis. The migratory ability of the cells was evaluated using a wound healing assay， while their invasive capacity was assessed via a Transwell assay. Additionally， the clonogenic assay was used to determine the proliferative potential of SW?13 and NCI?H295R cells following VO（acac）? treatment. Results The CCK?8 results demonstrated that VO（acac）₂ inhibited the viability of SW?13 and NCI?H295R cells in a time? and concentration?dependent manner. Specifically， the half?maximal inhibitory concentrations （IC50） for VO（acac）₂ against SW?13 cells were 62.98 ± 6.67 μmol/L after 24 hours and （14.61 ± 1.66） μmol/L after 48 hours of treatment， while the corresponding IC50 values for NCI?H295R cells were 46.78 ± 7.89 μmol/L and 12.61 ± 2.98 μmol/L， respectively. Flow cytometry analysis revealed that VO（acac）₂ induced apoptosis in both SW?13 and NCI?H295R cells in a concentration?dependent manner （P < 0.05）. The wound healing assay indicated a significant reduction in the migratory rate of SW?13 and NCI?H295R cells with increasing concentrations of VO（acac）₂ （P < 0.05）. Transwell assay results showed that VO（acac）₂ significantly inhibited the invasive ability of SW?13 and NCI?H295R cells in a concentration?dependent fashion. Finally， the clonogenic assay confirmed that VO（acac）₂ suppressed the proliferative capacity of SW?13 and NCI?H295R cells in a concentration?dependent manner. Conclusion VO（acac）₂ inhibits the proliferation， migration， and invasion of human adrenocortical carcinoma cells （SW?13 and NCI?H295R）， while inducing apoptosis in these cell lines.

Key words: vanadyl bis（acetylacetonato）, adrenocortical carcinoma, proliferation, invasion, apoptosis

CLC Number:

R586.9

Meiyu GAN,Chunjiao WU,Jingyi QIN,Zuojie. LUO. The effect of vanadyl bis（acetylacetonato） on the proliferation and invasion of human adrenocortical carcinoma cells[J]. The Journal of Practical Medicine, 2025, 41(6): 781-789.

Figures/Tables 11

Fig.1

Fig.2

Tab.1

Fig.3

Tab.2

Fig.4

Fig.5

Fig.6

Tab.3

Fig.7

Tab.4

References 40

1	BERRUTI A， BAUDIN E， GELDERBLOM H， et al. ESMO Guidelines Working Group. Adrenal cancer： ESMO Clinical Practice Guidelines for diagnosis， treatment and follow-up［J］. Ann Oncol， 2012，23 （）：vii 131-138. doi:10.1093/annonc/mds231 doi: 10.1093/annonc/mds231
2	BERRUTI A， GRISANTI S， PULZER A， et al. Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical Carcinoma［J］. J Clin Endocrinol Metab， 2017，102（4）：1358-1365. doi:10.1210/jc.2016-2894 doi: 10.1210/jc.2016-2894
3	TERZOLO M， ANGELI A， FASSNACHT M， et al. Adjuvant mitotane treatment for adrenocortical carcinoma［J］. N Engl J Med， 2007，356（23）：2372-2380. doi:10.1056/nejmoa063360 doi: 10.1056/nejmoa063360
4	LU D， YU N， MA X， et al. An ectopic adrenocortical adenoma in renal hilum presenting with Cushing's syndrome： A case report and literature review［J］. Medicine （Baltimore）， 2018，97（50）：e13322. doi:10.1097/md.0000000000013322 doi: 10.1097/md.0000000000013322
5	BUSSEY K J， BAPAT A， LINNEHAN C， et al. Targeting polo-like kinase 1， a regulator of p53， in the treatment of adrenocortical carcinoma［J］. Clin Transl Med， 2016，5（1）：1. doi:10.1186/s40169-015-0080-3 doi: 10.1186/s40169-015-0080-3
6	ZHENG S， CHERNIACK A D， DEWAL N， et al. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma［J］. Cancer Cell， 2016，30（2）：363.
7	DATTA J， ROSES R E. Surgical Management of Adrenocortical Carcinoma： An Evidence-Based Approach［J］. Surg Oncol Clin N Am， 2016，25（1）：153-170. doi:10.1016/j.soc.2015.08.011 doi: 10.1016/j.soc.2015.08.011
8	GONZALEZ R J， TAMM E P， NG C， et al. Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma［J］. Surgery， 2007，142（6）：867-875，discussion 867-875. doi:10.1016/j.surg.2007.09.006 doi: 10.1016/j.surg.2007.09.006
9	HUGHES M S， LO W M， BERESNEV T， et al. A Phase II Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Adrenocortical Carcinoma［J］. J Surg Res， 2018，232：383-388. doi:10.1016/j.jss.2018.06.012 doi: 10.1016/j.jss.2018.06.012
10	MEGERLE F， HERRMANN W， SCHLOETELBURG W， et al. German ACC Study Group. Mitotane Monotherapy in Patients With Advanced Adrenocortical Carcinoma［J］. J Clin Endocrinol Metab， 2018，103（4）：1686-1695. doi:10.1210/jc.2017-02591 doi: 10.1210/jc.2017-02591
11	唐玲，张英，申竹芳，等. 钒类化合物的抗糖尿病作用［J］. 中国临床药理学杂志， 2001，17（4）：298-302. doi:10.3969/j.issn.1001-6821.2001.04.015 doi: 10.3969/j.issn.1001-6821.2001.04.015
12	BRACKEN W M， SHARMA R P， ELSNER Y Y. Vanadium accumμLation and subcellμLar distribution in relation to vanadate induced cytotoxicity in vitro［J］. Cell Biol Toxicol， 1985，1（4）：259-268. doi:10.1007/bf00118191 doi: 10.1007/bf00118191
13	MEGERLE F， HERRMANN W， SCHLOETELBURG W， et al. German ACC Study Group. Mitotane Monothera in Patients With Advanced Adrenocortical Carcinoma［J］. J Clin Endocrinol Metab， 2018，103（4）：1686-1695. doi:10.1210/jc.2017-02591 doi: 10.1210/jc.2017-02591
14	REHDER D. The potentiality of vanadium in medicinal applications［J］. Future Med Chem， 2012，4（14）：1823-1837. doi:10.4155/fmc.12.103 doi: 10.4155/fmc.12.103
15	KIELER J， GROMEK A， NISSEN N I. Studies on the antineoplastic effect of vanadium salts［J］. Acta Chir Scand Suppl， 1965，343：154-164.
16	TSIANI E， FANTUS I G. Vanadium compounds biological actions and potential as pharmacological agents［J］.Trends Endocrinol Metab， 1997，8（2）：51-58. doi:10.1016/s1043-2760(96)00262-7 doi: 10.1016/s1043-2760(96)00262-7
17	PISANO M， ARRU C， SERRA M， et al. Antiproliferative activity of vanadium compounds： effects on the major malignant melanoma molecμLar pathways［J］. Metallomics， 2019，11（10）：1687-1699. doi:10.1039/c9mt00174c doi: 10.1039/c9mt00174c
18	DANKHOFF K， AHMAD A， WEBER B， et al. Anticancer properties of a new non-oxido vanadium（IV） complex with a catechol-modified 3，3'-diindolylmethane ligand［J］. J Inorg Biochem， 2019，194：1-6. doi:10.1016/j.jinorgbio.2019.02.005 doi: 10.1016/j.jinorgbio.2019.02.005
19	ZHANG Y， WANG L， ZENG K， et al.Vanadyl complexes discriminate between neuroblastoma cells and primary neurons by inducing cell-specific apoptotic pathways［J］. J Inorg Biochem， 2018，188：76-87. doi:10.1016/j.jinorgbio.2018.08.005 doi: 10.1016/j.jinorgbio.2018.08.005
20	WU J X， HONG Y H， YANG X G. Bis（acetylacetonato）-oxidovanadium（IV） and sodium metavanadate inhibit cell proliferration via ROS-induced sustained MAPK/ERK activation but with elevated AKT activity in human pancreatic cancer AsPC-1 cells［J］. J Aiol Inorg Chem， 2016，21（8）：919-929. doi:10.1007/s00775-016-1389-0 doi: 10.1007/s00775-016-1389-0
21	GOLDWASER I， GEFEL D， GERSHONOV E， et al. Insulin-like effects of vanadium： Basic and clinical implications［J］. J Inorg Biochem， 2000，80（1-2）：21-25. doi:10.1016/s0162-0134(00)00035-0 doi: 10.1016/s0162-0134(00)00035-0
22	MAKINEN M W， BRADY M J. Structural origins of the insulin-mimetic activity of bis（acetylacetonato）oxovanadium（IV）［J］. J Biol Chem， 2002，277（14）：12215-12220. doi:10.1074/jbc.m110798200 doi: 10.1074/jbc.m110798200
23	REUL B A， AMIN S S， BUCHET J P，et al. Effects of vanadium complexes with organic ligands on glucose metabolism： A comparison study in diabetic rats［J］. Br J Pharmacol， 1999，126（2）：467-77. doi:10.1038/sj.bjp.0702311 doi: 10.1038/sj.bjp.0702311
24	田生平，王崇山，杨伟忠. 肾上腺皮质肿瘤中mTOR信号通路的表达及其与细胞侵袭、血管新生的关系［J］. 海南医学院学报， 2018，24（11）：1120-1123. doi:10.13210/j.cnki.jhmu.20180425.002 doi: 10.13210/j.cnki.jhmu.20180425.002
25	ŞISMAN P， ŞAHIIN A B， PEYNIRCI H， et al. Adrenocortical carcinoma： Single center experience［J］. Turk J Urol， 2017，43（4）：462-469. doi:10.5152/tud.2017.81598 doi: 10.5152/tud.2017.81598
26	WANG S， GAO W C， CHEN S S， et al. Primary site surgery for metastatic adrenocortical carcinoma improves survival outcomes： an analysis of a popμLation-based database［J］. Onco Targets Ther， 2017， 10：5311-5315. doi:10.2147/ott.s147352 doi: 10.2147/ott.s147352
27	MUKHERJEE B， PATRA B， MAHAPATRA S， et al. Vanadium-an element of atypical biological significance［J］. Toxicol Lett，2004，150（2）：135-143. doi:10.1016/j.toxlet.2004.01.009 doi: 10.1016/j.toxlet.2004.01.009
28	REHDER D. The role of vanadium in biology［J］. Metallomics，2015，7（5）：730-742. doi:10.1039/c4mt00304g doi: 10.1039/c4mt00304g
29	BISHAYEE A， WAGHRAY A， PATEL M A， et al. Vanadium in the detection， prevention and treatment of cancer： The in vivo evidence［J］. Cancer Lett， 2010，294（1）：1-12. doi:10.1016/j.canlet.2010.01.030 doi: 10.1016/j.canlet.2010.01.030
30	PETANIDIS S， KIOSEOGLOU E， SALIFOGLOU A. Metallodrugs in Targeted Cancer Therapeutics： Aiming at Chemoresistance- related Patterns and Immunosuppressive Tumor Networks［J］. Curr Med Chem， 2019，26（4）：607-623. doi:10.2174/0929867324666171116125908 doi: 10.2174/0929867324666171116125908
31	SANCHEZ-LOMBARDO I， ALVAREZ S， MCLAUCHLAN C C，et al.Evaluating transition state structures of vanadium-phosphatase protein complexes using shape analysis［J］. J Inorg Biochem， 2015，147：153-164. doi:10.1016/j.jinorgbio.2015.04.005 doi: 10.1016/j.jinorgbio.2015.04.005
32	HUANG C， ZHANG Z， DING M，et al.Vanadate induces p53 transactivation through hydrogen peroxide and causes apoptosis［J］. J Biol Chem， 2000，275（42）：32516-32522. doi:10.1074/jbc.m005366200 doi: 10.1074/jbc.m005366200
33	HUANG C， DING M， LI J， et al. Vanadium-induced nuclear factor of activated T cells activation through hydrogen peroxide［J］.J Biol Chem， 2001，276（25）：22397-22403. doi:10.1074/jbc.m010828200 doi: 10.1074/jbc.m010828200
34	MARKOPOULOU， KONTARGIRIS E， BATSI C， et al.Vanadium-induced apoptosis of HaCaT cells is mediated by c-fos and involves nuclear accumμLation of clusterin［J］. FEBS J， 2009，276（14）：3784-3799. doi:10.1111/j.1742-4658.2009.07093.x doi: 10.1111/j.1742-4658.2009.07093.x
35	ZHANG Z， CHEN F， HUANG C， et al.Vanadate induces G2/M phase arrest in p53-deficient mouse embryo fibroblasts［J］. J Environ Pathol Toxicol Oncol， 2002，21（3）：223-231. doi:10.1615/jenvironpatholtoxicoloncol.v21.i3.30 doi: 10.1615/jenvironpatholtoxicoloncol.v21.i3.30
36	WANG Q， LIU T T， FU Y，et al.Vanadium compounds discriminate hepatoma and normal hepatic cells by differential regulation of reactive oxygen species［J］. J Biol Inorg Chem， 2010，15（7）：1087-1097. doi:10.1007/s00775-010-0668-4 doi: 10.1007/s00775-010-0668-4
37	ABAKUMOVA O I U， PODOBED O V， BELIAEVA N F， et al. Anticancer activity of oxovanadium compounds［J］. Biomed Khim， 2013，59（3）：305-320. doi:10.18097/pbmc20135903305 doi: 10.18097/pbmc20135903305
38	FU Y， WANG Q， YANG X G， et al. Vanadyl bisacetylacetonate induced G1/S cell cycle arrest via high-intensity ERK phosphorylation in HepG2 cells［J］. J Biol Inorg Chem， 2008，13（6）：1001-1009. doi:10.1007/s00775-008-0387-2 doi: 10.1007/s00775-008-0387-2
39	WU J X， HONG Y H， YANG X G. Bis（acetylacetonato）-oxidovanadium（IV） and sodium metavanadate inhibit cell proliferation via ROS-induced sustained MAPK/ERK activation but with elevated AKT activity in human pancreatic cancer AsPC-1 cells［J］. J Biol Inorg Chem， 2016， 21（8）：919-929. doi:10.1007/s00775-016-1389-0 doi: 10.1007/s00775-016-1389-0
40	SHUKLA R， BARVE V， PADHYE S， et al. Reduction of oxidative stress induced vanadium toxicity by complexing with a flavonoid， quercetin： A pragmatic therapeutic approach for diabetes［J］. Biometals， 2006，19（6）：685-693. doi:10.1007/s10534-006-9005-3 doi: 10.1007/s10534-006-9005-3

组别	SW-13	NCI-H295R
VO-0	5.43 ± 1.90	5.21 ± 1.30
VO-6.25	29.75 ± 8.36^??	29.66 ± 6.98^??
VO-12.5	41.29 ± 6.12^?	42.39 ± 7.58^?
VO-25	57.41 ± 6.00^?	50.68 ± 3.71

组别	SW-13	NCI-H295R
VO-0	443.00 ± 17.892	285.44 ± 13.684
VO-6.25	213.44 ± 15.152^???	172.22 ± 27.011^???
VO-12.5	75.00 ± 8.667^???	78.00 ± 5.207^???
VO-25	30.22 ± 5.748^??	29.89 ± 8.701^??

组别	SW-13	NCI-H295R
VO-0	398.00 ± 54.836	459.00 ± 20.664
VO-6.25	155.00 ± 26.058***	199.33 ± 2.082***
VO-12.5	72.33 ± 1.528*	105.00 ± 9.539***
VO-25	22.00 ± 5.568	70.00 ± 7.937**

[1]	Wei WANG,Min WANG,Minmin CHENG,Tingting. ZHANG. Impacts of safflower polysaccharide on tumor growth and PI3K/Akt/mTOR signal pathway in mice with colorectal cancer [J]. The Journal of Practical Medicine, 2025, 41(5): 670-675.
[2]	Hongyan BIAN,Shu ZHANG,Shanshan MENG,Ying WEI. Effect of pomegranate peel polyphenols on the malignant biological behavior of colon cancer cells by regulating the miR⁃138⁃5p/HIF⁃1α pathway [J]. The Journal of Practical Medicine, 2025, 41(5): 676-682.
[3]	Huixia YANG,Ning DING,Runqiu MA,Guizhong LI,Yinju HAO,Shengchao MA,Yideng JIANG,Zhigang. BAI. Role and mechanism of circular RNA mmu_circ_0000818 in dexamethasone⁃induced apoptosis of MC3T3⁃E1 cells [J]. The Journal of Practical Medicine, 2025, 41(4): 478-489.
[4]	Zonglin LI,Chunlin FENG,Xin LIU,Xingming SHU,Min. SONG. CCCTC⁃binding factors promote the formation of oxaliplatin related gastric cancer drug-tolerant cells by resisting apoptosis [J]. The Journal of Practical Medicine, 2025, 41(4): 490-499.
[5]	Zhizhou XIAO,Ying HUANG,Huawei. BIAN. To investigate the effect of aloperine on bone metabolism in osteoporotic mice based on autophagy and apoptosis mediated by Wnt/β⁃catenin signaling pathway [J]. The Journal of Practical Medicine, 2025, 41(4): 500-508.
[6]	Yufen LU,Xiaoming ZHENG,Shaojuan WEI,Liqin CHEN,Tongtong XU,Xiangwei. LÜ. Effects of miR⁃483⁃3p on hypoxia/reoxygenation⁃induced apoptosis and pyroptosis in cardiomyocytes [J]. The Journal of Practical Medicine, 2025, 41(3): 339-346.
[7]	Shan LUO,Ying FENG,Dandan FAN,Wenxin ZHENG,Xingrong GUO,Xuzhi. RUAN. ANGPTL8 knockout reduces lipopolysaccharide⁃induced hepatic lipid deposition [J]. The Journal of Practical Medicine, 2024, 40(9): 1197-1203.
[8]	Wei HE,Liping LIU,Jingwei ZHUO,Xiaodong ZHANG,Tong YANG,Jubin. FENG. CCR5 blockade reduces tumor growth by inducing apoptosis and impairing immunosuppression of tumor microenvironment [J]. The Journal of Practical Medicine, 2024, 40(9): 1204-1210.
[9]	Jing LIU,Chuntao LENG,Yan. WANG. Study on the angiogenic ability of exosomes derived from dental pulp stem cells modified by circRNA SIPA1L1 [J]. The Journal of Practical Medicine, 2024, 40(9): 1211-1217.
[10]	Wenxin LI,Minjun LU,Li LIN,Yueqin LIU,Xiaolan. ZHU. circRAF1 regulates the proliferation and apoptosis of human ovarian granulosa cells [J]. The Journal of Practical Medicine, 2024, 40(7): 910-917.
[11]	Zhen YANG,Shaoru JIANG,Xiaoyan CHEN,Xiaolin CHEN,Weimin DENG,Xinyu. GUO. Effect of Jinghou Zengzhi Granules on ovarian GDF9 secretion and granulosa cells apoptosis in controlled ovarian hyperstimulation rats [J]. The Journal of Practical Medicine, 2024, 40(7): 918-923.
[12]	Li′na GAO,Xiaohui LIU,Yufang ZHANG,Xiaoling LIU,Xiaochun HE,Jing GAO,Li ZHANG,Jun SUN,Xiujuan WANG,Yan. DONG. Expression of lncRNA SNHG8 in placenta accreta and its effect on trophoblast invasion and migration [J]. The Journal of Practical Medicine, 2024, 40(5): 646-652.
[13]	Li XU,Shanshan HU,Haiming. ZHAO. LncRNA GNAS⁃AS1 participates in the proliferation and migration of gastric cancer cells by regulating the miR⁃449a/Notch1 axis [J]. The Journal of Practical Medicine, 2024, 40(4): 483-489.
[14]	Runwei MA,Chunjie MU,Wenting GUI,Yao DENG,Minzhang ZHAO,Min LIU,Yi SONG. LncRNA SENCR targeted miR⁃206 regulates proliferation and apoptosis of human vascular smooth muscle cells of aortic dissection tissues [J]. The Journal of Practical Medicine, 2024, 40(3): 302-308.
[15]	Lihong DING,Shijia GENG,Yujie WANG. Effects of wedelobata on apoptosis and secretion of inflammatory cytokines in the alveolar epithelium infected by Streptococcus pneumonia [J]. The Journal of Practical Medicine, 2024, 40(3): 316-320.

The effect of vanadyl bis（acetylacetonato） on the proliferation and invasion of human adrenocortical carcinoma cells

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 11

References 40

Related Articles 15

Recommended Articles

Metrics

Comments

细胞	IC₅₀（24 h）	IC₅₀（48 h）
SW-13	62.98 ± 6.67	14.61 ± 1.66
NCI-H295R	46.78 ± 7.89	12.61 ± 2.98